Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease
(NYSE: LCTX) Delayed: 1.26 +0.05 (4.13%)
Previous Close $1.21    52 Week High $ 
Open $1.24    52 Week Low $ 
Day High $1.28    P/E N/A 
Day Low $1.22    EPS $ 
Volume 1,514,939       

(NYSE: LCTX) Delayed: 1.26 +0.05 (4.13%)
Previous Close $1.21    52 Week High $ 
Open $1.24    52 Week Low $ 
Day High $1.28    P/E N/A 
Day Low $1.22    EPS $ 
Volume 1,514,939